CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection.
about
RNA-guided editing of bacterial genomes using CRISPR-Cas systemsEvolutionary Ecology of Prokaryotic Immune MechanismsDiversity of CRISPR-Cas immune systems and molecular machinesComparative genomics of defense systems in archaea and bacteriaCRISPR-Cas systems: Prokaryotes upgrade to adaptive immunityCRISPR-Cas systems and RNA-guided interferenceCRISPR-Cas: biology, mechanisms and relevanceSteady at the wheel: conservative sex and the benefits of bacterial transformationSurvival and Evolution of CRISPR-Cas System in Prokaryotes and Its ApplicationsResistance and tolerance to foreign elements by prokaryotic immune systems - curating the genomeAddiction of Hypertransformable Pneumococcal Isolates to Natural Transformation for In Vivo Fitness and VirulenceHarnessing CRISPR-Cas9 immunity for genetic engineeringDynamics of adaptive immunity against phage in bacterial populations.Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations.Parallel evolution of Streptococcus pneumoniae and Streptococcus mitis to pathogenic and mutualistic lifestylesA CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion.Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.CRISPR-Cas systems: beyond adaptive immunity.CRISPR-Cas immunity in prokaryotes.CRISPR/Cas9-mediated viral interference in plantsFunction and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems.Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.Insights into the CRISPR/Cas system of Gardnerella vaginalisProgrammed protection of foreign DNA from restriction allows pathogenicity island exchange during pneumococcal transformation.Diversification of bacterial genome content through distinct mechanisms over different timescales.A CRISPR design for next-generation antimicrobials.Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens.Comparative genome analysis and identification of competitive and cooperative interactions in a polymicrobial diseaseRole of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.Evolution of the CRISPR-Cas adaptive immunity systems in prokaryotes: models and observations on virus-host coevolution.No evidence of inhibition of horizontal gene transfer by CRISPR-Cas on evolutionary timescales.CRISPR Content Correlates with the Pathogenic Potential of Escherichia coliSurvey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.Differential Distribution of Type II CRISPR-Cas Systems in Agricultural and Nonagricultural Campylobacter coli and Campylobacter jejuni Isolates Correlates with Lack of Shared EnvironmentsCRISPR/Cas9-The ultimate weapon to battle infectious diseases?
P2860
Q24630389-7EFBAF80-102B-4E5E-A4F9-4C9F30077DAAQ26740457-9D0FE7D2-FAB2-40A8-BE84-9C6A9D68139FQ26778564-E8A8AA64-2D47-4A5F-B9BE-AF3F1857FD58Q26829917-1C01F369-CC69-47AA-8E5E-FACAB232E42EQ27014828-F83F6583-3D75-4EA1-91CC-27672898A5B6Q27015486-7D540342-6D55-448A-A395-40D455000391Q28069426-B7713430-92DF-466B-BD1B-4095FEEC0908Q28071731-E71C933B-9356-49CC-B8DA-13ED67861553Q28079111-414E28D4-D851-4508-983E-692B4E686983Q28081298-8FA81C45-53BE-4453-A3B1-E4D584676758Q28274748-013520C7-5CE8-480B-92CB-BBDEEE7174F3Q29114115-18A2BDAD-2636-4160-B9C3-E1856757E2C8Q30252615-6EC2B036-6B32-4B01-89F2-092F0E93DEA7Q33790345-7396D900-154B-4AA5-BFD3-7F4CB74A516DQ33853796-59260BD1-FD0D-40D8-A6EC-AE3891B099BBQ33995376-1681A107-6E8A-4E11-9402-D510A316641EQ34002469-3E521E5D-A9FE-402A-920B-F621B9A2B4A3Q34037839-3257D6F7-8D69-4396-8A73-136068137279Q34038379-D0E128D5-EC79-43EB-9F74-3B5CFC9C1E1EQ34040445-DFBB9390-44D3-498A-A279-7973D868766CQ34045076-F9830971-F2CC-4C5A-A0D0-320F4F350077Q34045362-3CD33DCF-6E00-4643-A31F-21CF104BDC9DQ34314875-5308D1C1-5F54-459C-A64D-09090B9250E6Q34400621-A117943D-6638-4AA3-AACD-2A974891209AQ34439737-3D0C0C52-D0FE-450D-A45A-53E0E7F82E8CQ34520073-1AE34EFF-4E4B-4C09-B290-008847318DF7Q34607990-FC6CE4C2-8BE7-41AC-B839-866A981C94F2Q34677663-C3117A9E-1503-4FD2-813A-FECEA88C69B9Q34803114-0626DC1D-29E8-4019-A144-477860E50694Q35050042-0EDDE6F6-D313-4ECF-9937-08D58D0882EEQ35069169-964DB60A-7410-447E-91E2-827A5047520FQ35092513-CBDC440C-FBF4-4629-B086-620D4B5450FAQ35100510-F9038E54-7698-4F53-AE23-5A56B3C71428Q35265236-C490BC8D-3A0D-4132-80F9-131C94B00DECQ35566797-9A8CCD6D-D22F-4EF1-B317-B8847912A8D4Q35681328-E1C3AE30-150A-473E-8D89-C548ED5175ADQ35735874-88A98223-C643-4081-A83F-E46D580EEB73Q35740389-6F7B57D5-F9F3-4172-8211-5A4BCE95B3C3Q36166697-57AF113F-21E9-448E-BD77-45A15DBC7056Q36196813-88DD21CB-37EE-42FE-A1C6-748366F2529E
P2860
CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
CRISPR interference can preven ...... g in vivo bacterial infection.
@en
CRISPR interference can preven ...... g in vivo bacterial infection.
@nl
type
label
CRISPR interference can preven ...... g in vivo bacterial infection.
@en
CRISPR interference can preven ...... g in vivo bacterial infection.
@nl
prefLabel
CRISPR interference can preven ...... g in vivo bacterial infection.
@en
CRISPR interference can preven ...... g in vivo bacterial infection.
@nl
P1433
P1476
CRISPR interference can preven ...... g in vivo bacterial infection.
@en
P2093
Asma Hatoum-Aslan
Luciano A Marraffini
P304
P356
10.1016/J.CHOM.2012.06.003
P577
2012-08-01T00:00:00Z